External factors: | Doxorubicin |
Aging type: | Accelerate |
Aging characteristic: |
Category: | Chemical compounds |
Phenotype: | Synovial sarcoma |
Experiment: | SA-β-gal activity assay |
Description: | When control and doxorubicin-treated cultures were assayed for β-gal activity, only the FU-SY-1 SS cell line showed a significant (p<0.05) increase over controls in the percentage of cells considered β-gal positive. |
Regulatory pathway: | -- |
R-EF-Pathway: | -- |
Pathway experiment: | -- |
Pathway description: | -- |
Annotation: